The storied success of sildenafil has undeniably transformed the healthcare landscape. However, putting money in companies heavily reliant on biosimilars and the waning patent exclusivity surrounding this https://directmysocial.com/story6149230/the-blue-pill-and-pharmaceutical-companies-a-uncertain-investment